Seasonal Allergic Rhinitis Market Size

Market Size in USD Bn

CAGR3.1%

Study Period	2025-2032
Base Year of Estimation	2024
CAGR	3.1%
Market Concentration	Medium
Major Players	Regeneron Pharmaceuticals, Revolo Biotherapeutics, Allergy Therapeutics, Emergo Therapeutics, ALKAbello and Among Others

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Seasonal Allergic Rhinitis Market Analysis

The seasonal allergic rhinitis market is estimated to be valued at USD 11.14 billion in 2025 and is expected to reach USD 13.79 billion by 2032, growing at a compound annual growth rate (CAGR) of 3.1% from 2025 to 2032. The market is expected to showcase steady growth over the forecast period owing to the rising prevalence of allergic rhinitis and growing environmental pollution levels across the globe.